Trial Profile
Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Non-Small Cell Lung Cancer (NSCLC) Patients With IIIB Disease - A Multicenter Phase II Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel
- Indications Adenocarcinoma; Large cell carcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 10 Mar 2022 Status changed from active, no longer recruiting to completed.
- 26 Nov 2021 Planned End Date changed from 1 Sep 2021 to 1 Jan 2022.
- 02 Jun 2021 Planned End Date changed from 1 Jun 2021 to 1 Sep 2021.